BGASX
Price
$16.12
Change
+$0.03 (+0.19%)
Updated
May 9 closing price
Net Assets
715.2M
RNPEX
Price
$62.30
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
142.32B
Ad is loading...

BGASX vs RNPEX

Header iconBGASX vs RNPEX Comparison
Open Charts BGASX vs RNPEXBanner chart's image
Baillie Gifford Global Alpha Equities I
Price$16.12
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets715.2M
American Funds New Perspective R4
Price$62.30
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets142.32B
BGASX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BGASX vs. RNPEX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGASX is a Buy and RNPEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 142B vs. BGASX (715M). BGASX pays higher dividends than RNPEX: BGASX (1.23) vs RNPEX (0.55). BGASX was incepted earlier than RNPEX: BGASX (8 years) vs RNPEX (23 years). RNPEX (0.76) and BGASX (0.75) have similar cost to investors . BGASX is a more actively managed with annual turnover of: 28.00 vs. RNPEX (24.00). BGASX has a lower initial minimum investment than RNPEX: BGASX (0) vs RNPEX (250). RNPEX annual gain was more profitable for investors over the last year : 5.27 vs. BGASX (-4.45). RNPEX return over 5 years is better than : 46.39 vs. BGASX (9.65).
BGASXRNPEXBGASX / RNPEX
Total Expense Ratio0.750.7699%
Annual Report Gross Expense Ratio0.750.7699%
Fund Existence8 years23 years-
Gain YTD0.1862.2828%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets715M142B1%
Annual Yield % from dividends1.230.55226%
Returns for 1 year-4.455.27-84%
Returns for 3 years21.8527.4180%
Returns for 5 years9.6546.3921%
Returns for 10 yearsN/A64.04-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALZN0.660.12
+21.87%
Alzamend Neuro Inc.
REPL7.71-0.06
-0.77%
Replimune Group
ASGN55.69-0.73
-1.29%
ASGN
TOI2.80-0.12
-4.11%
Oncology Institute (The)
AFRM46.41-7.85
-14.47%
Affirm Holdings